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Purpose: Keratoconus (KC) is a common progressive corneal disease characterized by excessive stromal thinning, central
or paracentral conical protrusion, and disruptions in Bowman’s layer. The etiology of KC is largely unknown, and a
combination of genetic and environmental factors is believed to play a role in the origin of the disease. Recently, the
absence of transcripts of the water channel, aquaporin-5 (AQP5), was demonstrated by reverse-transcription polymerase
chain reaction (RT–PCR) in KC tissues and was proposed as a possible marker for KC. In this study, we sought to evaluate
AQP5 mRNA and protein expression in KC and non-KC corneal tissues using a combination of techniques.
Methods: A total of 69 samples of corneal tissue were analyzed including 39 corneal buttons from patients with advanced
KC, 16 samples of non-KC corneal epithelium belonging to patients who underwent surface refractive surgery, 12
sclerocorneal rims obtained from healthy donor subjects, and two healthy corneal buttons. Determination of AQP5
transcript and protein expression patterns was performed by means of real time RT–PCR, immunohistochemistry,
immunocytochemistry, and flow cytometry methods. Cell culture was performed to identify AQP5 protein expression in
KC epithelial cells.
Results: AQP5 mRNA was expressed with no significant differences between KC and non-KC tissues. Moreover, AQP5
protein expression analysis did not reveal differences in protein levels and/or cell location among KC and non-KC tissues.
Interestingly, AQP5 expression continues for up to 21 days in the isolated KC corneal epithelial cells.
Conclusions: Our results do not support a role for AQP5 in KC etiopathogeny or as a disease marker. Genetic background
differences or a distinct pathogenetic KC cascade specific to the analyzed population could account for the dissimilarities
observed in KC-related AQP5 expression.
Keratoconus (KC) is a heterogeneous disorder in which
the cornea assumes a conical shape as a consequence of a
gradually  progressive  non-inflammatory  thinning  of  the
corneal stroma. Corneal thinning in KC individuals induces
irregular  astigmatism,  myopia,  and  central  or  paracentral
conical protrusion. The calculated incidence of KC is between
1 in 500 and 1 in 2,000 individuals in the general population
[1] with the disease being the most common indication for
penetrating  keratoplasty  in  developed  countries  [2].
Histopathological features of keratoconic corneas have been
clearly defined and include stromal thinning, iron deposits in
the epithelial basement membrane, and breaks in Bowman's
layer [3]. The etiology of KC is largely unknown, and genetic
and environmental factors are believed to play a role in distinct
analyzed  populations  [4].  Most  cases  of  KC  occur
sporadically, but it has been estimated that up to 10% of cases
has  a  positive  familial  history  for  the  disease  [5].  This
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observation  along  with  the  occurrence  of  the  disorder  in
monozygotic twins and the bilateralism of the disease strongly
suggest  that  genetic  factors  are  important  for  KC
development. In families with KC Mendelian transmission,
autosomal dominant and autosomal recessive inheritance has
been established. In addition, genome-wide linkage analyses
in familial cases have evidenced several chromosomal regions
that  harbor  potential  KC-causing  genes  including  5q14.3-
q21.1,  16q22.3-q23.1  [6],  3p14-q13  [7],  and  2p24  [8].
However,  a  definitive  KC-causing  gene  has  not  been
identified to date. As the disease initiates typically during
adolescence,  the  identification  of  a  molecular  marker
associated  to  the  development  of  the  disease  would  be
particularly helpful in the early identification of individuals at
risk of developing KC.
The aquaporins (AQPs) constitute a large family of water
channels  that  play  a  critical  role  in  transcellular  water
movement in many tissues [9]. The aquaporin-5 (AQP5) gene
is normally expressed in corneal epithelial cells where it is
presumably involved in fluid elimination as supported by the
observation that Aqp5 null mice exhibit abnormalities in both
corneal thickness and corneal epithelial water permeability
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756[10].  Recently,  the  absent  expression  of  AQP5  from  the
corneal epithelium was shown to be a feature of KC corneas
[11]. However, no additional studies have been performed to
validate the possible involvement of AQP5 in KC. To further
investigate this issue, we analyzed the expression of this gene
in  KC  and  healthy  corneal  tissues  using
immunohistochemistry, real time polymerase chain reaction
(PCR), flow cytometry, and immunocytochemistry.
METHODS
Corneal samples: Sixty-nine samples of corneal tissue were
obtained; 39 samples were corneal buttons from patients with
KC, 16 were samples of corneal epithelium of patients who
underwent  surface  refractive  surgery  (Photorefractive
Keratectomy  or  Epi-LASIK),  12  were  sclerocorneal  rims
obtained from healthy donor subjects, and two buttons were
from healthy corneas. In the keratoconus group, the mean age
was 25 years (range 14–48 years), 68% were male and 32%
were female. All KC cases correspond to advanced or late-
stage instances of the disease confirmed by clinical (central
or paracentral leukomas, Vogt’s striae, and severe corneal
stromal thinning) and corneal topographic criteria. Patients
gave the appropriate permissions for their corneas to be used
for this research. All tissues were obtained within 24 h after
surgery. Samples were rinsed with 0.15 M phosphate-buffered
saline (PBS) and divided into two pieces unless otherwise
stated. One fragment of each sample was paraffin embedded
whereas the other fragment was used for molecular analysis.
Tissue  RNA  extraction  and  conventional  reverse-
transcription  polymerase  chain  reaction:  RNA  extraction
from 10 KC and 7 non-KC corneal samples was achieved
using  the  RNAeasy  kit  (Qiagen,  Heiden,  Germany)  as
indicated  by  the  manufacturer.  Retrotranscription  was
performed with the Omniscript kit (Qiagen) according to the
manufacturer’s  instructions.  The  RNA  concentration  was
evaluated  by  A260/A280  measurement  and  was
retrotranscribed at 37 °C for 1 h in the presence of oligo dT
(Invitrogen, Carlsbad, CA). The PCR reaction for AQP5 was
performed with Hotstart DNA Polymerase (Qiagen) using the
following pair of primers, forward 5′-CGT TTG GCC TGG
CCA TAG GCA−3′ and reverse 5′-TGG CCC TGC GTT GTG
TTG  TTG−3′.  Band  intensities  of  PCR  products  were
quantified by densitometric scanning using the Kodak 1D
Image Analysis software (Kodak, Rochester, NY), and values
were  normalized  against  amplification  of  GAPDH  as  a
constitutive gene.
Real  time  polymerase  chain  reaction:  From  the  obtained
cDNA,  real  time  PCR  was  performed  using  the
phosphoglycerate  kinase  1  (PGK-1)  gene  as  previously
described [12]. Up to 5 ng of starting RNA was used for
amplification in a Rotor-Gene 6000 apparatus (Corbett Life
Science, Sidney, Australia). Primers for PGK-1 and AQP5
amplification had the same melting temperature and were
PGK-1 forward 5′-ATT AGC CGA GCC AGC CAA AAT
AG-3′, PGK-1 reverse 5′-TCA TCA AAA ACC CAC CAG
CCT TCT-3′, AQP5 forward 5′-CAT CTT CGC CTC CAC
TGA CT-3′, and AQP5 reverse 5′-CCC TAC CCA GAA AAC
CCA GT-3′. To identify that the amplification reactions did
not form any spurious sub-products, the temperature gradient
was performed from 75 °C to 95 °C and was analyzed by melt
curve. In all cases, only one curve was obtained for each
amplification reaction. Relative amplification increment was
calculated  using  the  formula,  AQP5Ct/PGK1Ct.  Each
experiment was done in triplicate in five independent assays.
Comparisons  between  groups  were  performed  using  the
Student’s unpaired t-test and were considered to be significant
if p<0.05.
Automated DNA sequencing: AQP5 products amplified by
reverse-transcription (RT)–PCR were directly sequenced to
confirm the identity of the amplicon. Nucleotide sequence was
Figure 1. Electrophoretic analysis of conventional AQP5 reverse-
transcription polymerase chain reaction in keratoconus and non-
keratoconus corneal tissue. Amplicons for AQP5 were visualized in
a 1.5% agarose ethidium bromide gel from both samples KC and
non-KC corneal tissue. Lane 2, corresponds to AQP5 amplicon from
KC corneal tissue; lane 3, corresponds to AQP5 amplicon from non-
KC corneal tissue. Molecular weight markers are shown in lane 1.
Similar bands intensities are observed.
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757achieved  using  the  BigDye  terminator  kit  (Applied
Biosystems,  Foster  City,  CA)  of  fluorescently  labeled
terminators and analyzing the samples in an ABI 310 DNA
Sequencer (Applied Biosystems). Sequences were compared
to  the  published  human  wild  type  AQP5  gene  (Ensembl
transcript ID number ENST00000293599).
Immunohistochemistry:  Twenty-nine  KC  and  14  non-KC
specimens  were  analyzed  by  immunohistochemistry.
Histological sections (5 μm thick) that were collected on poly-
L-lysine-coated slides were deparaffinized; the sections were
rehydrated in a xylene-graded alcohol scale and then rinsed
with PBS. Intrinsic peroxidase activity was blocked with 3%
H2O2 for 5 min at room temperature and then exposed to
primary  goat  anti-human  AQP5  antibody  (Santa  Cruz
Biotechnology, Santa Cruz, CA) for 1 h at room temperature.
After washing in 0.05% Tween 20-PBS, the sections were
exposed to universal biotin conjugated antibodies for 30 min
at  room  temperature.  The  sections  were  incubated  with
peroxidase-conjugated  streptavidin  for  20  min  at  room
temperature. The color development reaction was performed
with  diaminobenzidine  chromogen  and  0.05%  H2O2.  The
sections  were  counterstained  with  Meyer’s  hematoxylin
(Dako, Glostrup, Denmark). Human tonsil tissue for AQP5
immunohistochemistry  were  used  as  a  positive  control  as
previously  described  [13];  negative  controls  were  tissue
samples  in  which  the  primary  antibody  (AQP5)  was  not
added.
Cell  culture  and  immunocytochemistry:  Corneal  tissue
obtained  from  surgery  was  rinsed  with  PBS  twice  and
incubated with 1.2 IU/ml of Dispase II (Roche, Mannheim,
Germany) for 30 min at 37 °C. Five KC and five non-KC tissue
samples were cut into four pieces and seeded in 24 well plastic
culture plates for 20 min at 37 °C. A drop of 25 μl of heat
Figure 2. AQP5 real time polymerase chain reaction comparative
analysis in keratoconus and non-keratoconus corneal tissue. PCR
products  from  both  samples  KC  and  non-KC  corneal  tissue  are
shown. Curves A and B correspond to the PGK-1 gene amplification
from healthy and KC corneal tissue, respectively. Curves C and D
correspond to AQP5 amplification from healthy and KC corneal
tissue, respectively. The x-axis represents the number of cycles, and
the  y-axis  represents  normalized  fluorescence.  The  graph  is  a
representative example of five separate assays.
inactivated bovine fetal serum (Gibco, Carlsbad, CA) was
subsequently added to the tissue. After 24 h of incubation,
1 ml of keratinocyte serum free medium (Gibco) was added
and changed every other day. Cell culture was allowed until
90%  of  cell  confluence  was  reached.  As  the  cell  culture
control, limbal epithelial cells were cultured as described by
Luna-Baca et al. [14]. Cultured cells were attached into 12 mm
diameter  cover  glasses  for  24  h  at  37  °C  in  5%  CO2.
Afterwards, the cover glasses were fixed by adding ice-cold
absolute ethanol for 10 min. Intrinsic peroxidase activity was
blocked with 3% H2O2 for 5 min at room temperature and then
exposed to primary goat ant-human AQP5 antibody for 1 h at
room temperature. After washing in 0.05% Tween-PBS, the
sections  were  exposed  to  universal  biotin-conjugated
antibodies for 30 min at room temperature. The sections were
incubated with peroxidase-conjugated streptavidin for 20 min
at room temperature. The color development reaction was
performed  with  diaminobenzidine  chromogen  and  0.05%
H2O2.  The  immunoreaction  was  assessed  under  light
microscope.
Flow cytometry: Five KC and five non-KC corneal tissues
were incubated with 1.2 IU/ml Dispase II for 45 min at 37 °C.
After the addition of PBS, the cell suspension was extensively
triturated  through  a  fire-polished  Pasteur  pipette  and
sequentially filtered through 40 μm and 10 μm nylon mesh
sieves.  Five-hundred  microliters  of  4%  p-formaldehyde
(Sigma Aldrich, St Louis, MO) were added and incubated for
10 min at 4 °C. Cells were washed and incubated with 10 μl
of anti-human AQP5 (Santa Cruz Biotechnology) and anti-
human cytokeratin (Dako) antibodies for 30 min at room
temperature. After washing the cells twice, the pellet was
incubated with 20 μl of secondary fluorochrome-conjugated
antibodies (BD PharMingen, San Jose CA). The cells were
then analyzed by flow cytometry in a FACScalibur apparatus
(Becton Dickinson, La Jolla, CA). Suitable negative controls
were used.
Figure 3. AQP5 immunohistochemistry from keratoconus and non-
keratoconus  corneal  tissue.  A:  The  immunopositive  reaction  to
AQP5 from a KC sample is shown as a brown signal in the epithelial
cells.  B:  Non-KC  tissue  demonstrates  a  similar  immunopositive
AQP5  reaction.  Note  disruptions  in  Bowman’s  layer  in  A.  b,
Bowman’s layer; e, corneal epithelium; s, stroma (Representative
assay of 29 KC and 14 non-KC samples). Bar=100 µm.
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758Western blot: Total protein was obtained from corneal KC and
non-KC epithelial cells following standard conditions (details
on request). Proteins were separated by electrophoresis on
12%  SDS-polyacrylamide  gel  and  were  transferred  to  a
nitrocellulose membrane. The membrane was pre-incubated
with blocking buffer (5% non-fat milk, 0.05% Tween 20, and
TBS (100 mM Tris HCl, pH 8.0, 150 mM NaCl) for 2 h at
room temperature and incubated with polyclonal goat anti-
AQP5 antibody at 4 °C overnight. The membrane was then
washed in several changes of washing buffer (0.05% Tween
20 in TBS), incubated for 2 h with mouse anti-goat biotin-
conjugated  immunoglobulins  at  room  temperature.  The
membrane was washed in several changes of washing buffer
and incubated with anti-biotin, peroxidase-conjugated Fab
fragments for 1 h at room temperature. Proteins were detected
using  the  Western  Lightning  Chemiluminescence  reagent
(Perkin Elmer Life Science, Boston, MA).
RESULTS
Determination of AQP5 transcripts in corneal epithelial cells:
Band  intensities  of  PCR  products  were  compared  by
densitometric analysis (Figure 1). No statistically significant
differences (p>0.05) were observed between KC (n=10) and
non-KC corneal tissue (n=14). To determine if differences in
the  amplification  reaction  due  to  distinct  initial  RNA
concentration  existed,  real  time  PCR  was  performed,
normalizing with a constitutive PGK-1 gene. The average
relative  increment  of  samples  from  both  groups  ranged
between  1.01  and  1.05  with  no  statistically  significant
differences (p>0.05; Figure 2).
Nucleotidic sequence: The nucleotide sequence of the AQP5
amplicon disclosed a 100% homology with the wild type
AQP5 sequence.
Figure 4. AQP5 flow cytometry in epithelial cells from keratoconus
cornea. A: Flow cytometry dot plot from single cell suspension from
KC  cornea  labeled  with  anti-cytokeratin.  The  inner  rectangle
represents  cytokeratin  positive  cells  B:  AQP5  flow  cytometry
histogram is shown from cytokeratin positive cells. The continuous
dark line represents AQP5+ cells; the dashed light line represents the
negative control. Inner numbers indicate media ± SEM (n=5).
Corneal epithelial cells from keratoconus ex vivo and in vitro
express constitutively AQP5 protein: Immunohistochemistry
was performed on 29 samples of KC corneal epithelium, 12
samples  of  sclerocorneal  rims,  and  two  healthy  corneas.
Under light microscopy, no apparent differences in the pattern
of immunoreaction were observed comparing KC cells with
normal  corneal  epithelial  cells  (Figure  3).  When  the  cell
suspension of epithelial cells from KC was analyzed by flow
cytometry, almost 95% of cells were cytokeratin positive,
indicating that the major population of cells obtained from
corneal  tissue  treated  were  epithelial  cells.  From  those
epithelial cells, approximately 90% of the cells were positive
to AQP5 (Figure 4A,B). Western blot analysis revealed the
identification of two bands of similar intensity in both KC and
non KC samples (27 and 31 kDa, corresponding to the non-
glycosylated and glycosylated forms of the AQP5 protein,
respectively;  Figure  5).  Similarly,  when
immunocytochemistry  assays  were  performed  in  corneal
epithelial cells from KC and non-KC tissue grown in vitro, all
analyzed cells expressed constitutively the AQP5 protein. A
Figure 5. Western blot for AQP5 in keratoconus and non-keratoconus
epithelial cells. The photograph of a western blot identifies two bands
of  AQP5.  Twenty-seven  and  31  kDa  corresponds  to  the  non-
glycosylated protein and glycosylated form of the AQP5 protein,
respectively.  Lane  A  corresponds  to  a  non-KC  sample;  lane  B
corresponds to a KC sample. GAPDH protein is shown below as an
internal control.
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759similar pattern of AQP5 immunostaining was observed in
these KC and non-KC cells (Figure 6).
DISCUSSION
Aquaporin  water  channels  are  expressed  primarily  in  cell
plasma membranes where they function as selective pores
allowing  water,  glycerol,  and  other  small  solutes  to  pass
through the cell membrane. AQP5 plays an important role in
corneal fluid elimination via the corneal epithelium [15], and
Aqp5  null  mice  have  increased  corneal  thickness  due  to
corneal swelling [10]. These data along with the finding of the
absence of AQP5 transcripts from KC corneas [11] have led
to a proposal that there is a potential role for AQP5 in the
physiopathology of KC. In this study, we sought to compare
the expression of AQP5 in KC and non-KC corneal tissues by
means of several different techniques. Our results indicate that
AQP5 expression levels are similar in KC and non-KC corneas
and  that  the  immunolocalization  of  AQP5  did  not  differ
between  both  groups  when  analyzed  by
immunohistochemistry  and  immunocytochemistry.  In  our
study, corneal epithelial tissues from non-KC subjects were
compared to corneal buttons from KC. The difference in tissue
samples (corneal epithelium versus corneal buttons) did not
affect our conclusions as it has been demonstrated that AQP5
is exclusively expressed in corneal epithelial cells [15].
Controversial results have been reported regarding the
involvement of AQP5 in KC. Kenney et al. [16] found no
significant differences in the staining pattern for AQP5 in
epithelial cells of normal corneas and KC corneas. In contrast,
another study reported the absence of AQP5 transcripts from
KC tissues when analyzing clones from a human KC cornea
cDNA collection and by RT–PCR [11]. This finding was
interpreted as a possible feature of KC corneas. However, the
comprehensive evaluation of both AQP5 mRNA and protein
in KC tissues that we describe in this work argue against a
potential involvement of this aquaporin as a KC etiologic
factor or as a late-stage marker of the disease. The discrepancy
between our results and those previously published could be
explained  by  specific  genetic  differences  between  ethnic
Figure 6. AQP5 immunocytochemistry of cultured corneal epithelial
cells. A: Epithelial cells obtained from a cell culture of KC corneas
strongly immunoreact to AQP5. B: Epithelial cells cultured from
non-KC tissue display a similar pattern of AQP5 immunostaining.
This figure is representative of five separate assays.
groups, by the stage of KC development analyzed, which was
moderate to advanced KC in the Rabinowitz et al. study [11]
and exclusively advanced KC in our study, or by distinct
etiopathologic  factors  among  KC  subjects  from  different
populations.
Altogether, these data indicate that an abnormality in
AQP5  mRNA  or  protein  is  not  likely  involved  in  KC
physiopathology. In addition, to determine the possibility of
AQP5  mutations  occurring  in  DNA  from  KC  patients,  a
nucleotidic sequence of the AQP5 gene was performed in
several individuals with the disease, but no mutations were
identified [unpublished data]. This result is in agreement with
those reported by Rabinowitz et al. [11] who did not find
AQP5 mutations in DNA from KC corneas.
In our study, AQP5 staining by immunohistochemistry
revealed  a  punctate  rather  than  a  membrane-associated
epithelial pattern. This pattern is identical to that reported
previously [16]. An interesting find in this work was that
AQP5 expression is preserved in KC corneal epithelial cells
after 21 days of culture. This result suggests AQP5 could be
used as a suitable marker for cultured corneal epithelial cells.
In conclusion, we do not find evidence of AQP5 involvement
in KC corneal tissue in this sample of Mexican patients.
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